No recommendation
No news or research item is a personal recommendation to deal. Hargreaves Lansdown may not share ShareCast's (powered by Digital Look) views.
(Sharecast News) - Advanced Medical Solutions said on Monday that it expects first-half revenue of about 115.2m, up from 110.8m a year earlier, despite some orders slipping into early July and de-stocking linked to the expansion of direct sales in Europe.
The AIM-traded firm said the period also faced a strong comparator after order phasing from a key strategic partner boosted the Advance Closure division in the first half of 2025.
The group said the integration of Peters Surgical and Syntacoll remained on track and reiterated that full-year 2026 EBITDA was expected to meet current market forecasts.
Chief executive Chris Meredith said AMS remained confident in its long-term prospects, supported by its strengthened product portfolio and pipeline of opportunities.
At 1400 BST, shares in Advanced Medical Solutions Group were up 0.4% at 280.12p.
Reporting by Josh White for Sharecast.com.
See latest RNS on Investegate
The value of investments can go down in value as well as up, so you could get back less than you invest. It is therefore important that you understand the risks and commitments. This website is not personal advice based on your circumstances. So you can make informed decisions for yourself we aim to provide you with the best information, best service and best prices. If you are unsure about the suitability of an investment please contact us for advice.